An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A

Research Site, Rome

Research Site, Rome

Research Site, Auckland

Research Site, Westmead

Research Site, Parkville

Research Site, Brisbane

Research Site, Perth

Research Site, Christchurch

Research Site, New York

Research Site, Berlin

Research Site, Caen

Research Site, Buffalo

Research Site, Rochester

Research Site, Genova

Research Site, Philadelphia

Research Site, Milan

Research Site, Madrid

Research Site, Hannover

Research Site, Toulouse

Research Site, Padua

Research Site, Vicenza

Research Site, Tours

Research Site, Louisville

Research Site, Düsseldorf

Research Site, Columbus

Research Site, Nantes

Research Site, Indianapolis

Research Site, East Lansing

Research Site, Florence

Research Site, Bonn

Research Site, Milwaukee

Research Site, Minneapolis

Research Site, Lille

Research Site, Frankfurt

Research Site, St Louis

Research Site, Strasbourg

Research Site, Bari

Research Site, Little Rock

Research Site, Dallas

Research Site, Dallas

Research Site, Napoli

Research Site, Torrance

Research Site, Duarte

Research Site, San Francisco

Research Site, Le Kremlin-Bicêtre

Research Site, Sacramento

Research Site, Portland

Research Site, Brewer

Research Site, Campinas

Research Site, Canoas

Research Site, Ribeirão Preto

Research Site, Rio de Janeiro

Research Site, São Paulo

Research Site, Hamilton

Research Site, London

Research Site, Toronto

Research Site, Dublin

Research Site, Leiden

Research Site, Utrecht

Research Site, Gdansk

Research Site, Krakow

Research Site, Lublin

Research Site, Warsaw

Research Site, Barcelona

Research Site, Stockholm

Research Site, Cambridge

Research Site, Basingstoke

Research Site, Whitechapel

Research Site, Cardiff

Research Site, London

Research Site, Sheffield